Not applicableStudy completedNCT00900302What this trial is testingOX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With CancerWho this might be right forCancer OHSU Knight Cancer Institute 98
Testing effectiveness (Phase 2)Ended earlyNCT01382745What this trial is testingNimotuzumab With Radiotherapy in the Treatment of Anal Canal CancersWho this might be right forSquamous Cell Carcinoma of Anal Canal Dr. Te Vuong 1
Testing effectiveness (Phase 2)Study completedNCT05060471What this trial is testingPD-1 Blockade Combined With Chemotherapy Followed by Concurrent Immunoradiotherapy for Locally Advanced SCCA PatientsWho this might be right forAnal Canal CancerAnal Squamous Cell CarcinomaAnal Cancer+3 more Sun Yat-sen University 25
Not applicableLooking for participantsNCT04907643What this trial is testingVirtual Reality for GI Cancer Pain to Improve Patient Reported OutcomesWho this might be right forCancer PainVisceral PainGastrointestinal Neoplasms+76 more Cedars-Sinai Medical Center 360
Not applicableStudy completedNCT00059891What this trial is testingAnal Sphincter Prosthesis in Treating Patients Who Are Undergoing Surgery for Anal or Rectal CancerWho this might be right forAnal CancerColorectal CancerPerioperative/Postoperative Complications Memorial Sloan Kettering Cancer Center 4
Large-scale testing (Phase 3)Study completedNCT00025090What this trial is testingRadiation Therapy Plus Fluorouracil With or Without Additional Chemotherapy in Treating Patients With Primary Anal CancerWho this might be right forAnal Cancer University College London (UCL) Cancer Institute 600
Early research (Phase 1)Study completedNCT00020579What this trial is testingMS-275 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forCancer National Institutes of Health Clinical Center (CC) 75
Large-scale testing (Phase 3)Study completedNCT00003652What this trial is testingCombination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal CancerWho this might be right forAnal Cancer UNICANCER 350
Early research (Phase 1)Study completedNCT00031681What this trial is testing7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)Who this might be right forAdvanced Adult Primary Liver CancerCarcinoma of the AppendixEstrogen Receptor-negative Breast Cancer+85 more National Cancer Institute (NCI) 41
Post-approval studies (Phase 4)UnknownNCT00274885What this trial is testingRelationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal CancerWho this might be right forCancer GERCOR - Multidisciplinary Oncology Cooperative Group 58
Testing effectiveness (Phase 2)Study completedNCT00316888What this trial is testingCetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Anal CancerWho this might be right forAnal Cancer ECOG-ACRIN Cancer Research Group 63
Testing effectiveness (Phase 2)WithdrawnNCT04499352What this trial is testingTest BI 754091 Alone or in Combination With BI 836880 in People Who Have Advanced Anal CancerWho this might be right forAnal Canal Squamous Cell Carcinoma Boehringer Ingelheim
Testing effectiveness (Phase 2)Active Not RecruitingNCT04166318What this trial is testingLower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE StudyWho this might be right forAnal Basaloid CarcinomaAnal Canal Cloacogenic CarcinomaAnal Canal Squamous Cell Carcinoma+3 more ECOG-ACRIN Cancer Research Group 252
Large-scale testing (Phase 3)Study completedNCT00003596What this trial is testingChemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal CancerWho this might be right forAnal Cancer Radiation Therapy Oncology Group 682
Testing effectiveness (Phase 2)Study completedNCT03519295What this trial is testingMDCF in Combination or Not With Atezolizumab in Advanced Squamous Cell Anal CarcinomaWho this might be right forAnal Cancer GERCOR - Multidisciplinary Oncology Cooperative Group 97
Testing effectiveness (Phase 2)UnknownNCT00754078What this trial is testingA Phase II Study to Assess Acute Toxicity and Quality of Life of Patients With Carcinoma of the Anal Canal Receiving Chemotherapy and Radiation Using Helical TomotherapyWho this might be right forAnal Canal Cancer AHS Cancer Control Alberta 58
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Large-scale testing (Phase 3)Ended earlyNCT00068744What this trial is testingRadiation Therapy, Mitomycin, and Either Fluorouracil or Cisplatin in Treating Patients With Locally Advanced Anal CancerWho this might be right forAnal Cancer European Organisation for Research and Treatment of Cancer - EORTC 88
Testing effectiveness (Phase 2)Study completedNCT00423293What this trial is testingIntensity-Modulated Radiation Therapy, Fluorouracil, and Mitomycin C in Treating Patients With Invasive Anal CancerWho this might be right forAnal Cancer Radiation Therapy Oncology Group 63
Testing effectiveness (Phase 2)Study completedNCT01941966What this trial is testingSubstitution of 5-FU (Fluorouracil) by Capecitabine in Scheme of Chemo-radiotherapy in Patients With Squamous Cell Carcinoma of the Anal Canal.Who this might be right forAnal Canal Cancer. Instituto do Cancer do Estado de São Paulo 51